Finance

Lists
TTI:CVE
Thiogenesis Therapeutics Corp
CA$0.65
0.00%
(0.00) 1D
Nov 12, 3:21:37 PM GMT-5  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for TTI...
Mkt. cap
45.49M
Avg. vol.
20.38K
Volume
0.00
52-wk high
CA$0.72
52-wk low
CA$0.44
EPS
-CA$0.12
Beta
0.38
Shares outstanding
69.98M
Mkt. cap
45.49M
Avg. vol.
20.38K
Volume
0.00
52-wk high
CA$0.72
52-wk low
CA$0.44
EPS
-CA$0.12
Beta
0.38
Shares outstanding
69.98M
News stories
From web sources and news partners
About Thiogenesis Therapeutics Corp
CEO-
Employees-
Founded2018
HeadquartersToronto, Ontario, Canada
SectorHealth Care
IndustryPharmaceutical industry
Websitethiogenesis.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.92M
1.27M
579.55K
1.24M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
471.84K
464.40K
338.28K
242.34K
Operating expense
2.39M
1.73M
917.82K
1.48M
Total operating expenses
2.39M
1.73M
917.82K
1.48M
Operating income
-2.39M
-1.73M
-917.82K
-1.48M
Other non operating income
-
-
-
-
EBT including unusual items
-2.38M
-1.73M
-911.82K
-1.49M
EBT excluding unusual items
-2.38M
-1.73M
-911.82K
-1.49M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.38M
-1.73M
-911.82K
-1.49M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
6.45K
4.42K
51.00
2.18K
Interest expense
-
-
-
-
Net interest expenses
6.45K
4.42K
51.00
2.18K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps